FDX
36
-4
XYL
37
2
DVA
72
2
SRE
63
-3
ALLE
37
5
JNPR
46
3
KR
34
-3
BEN
45
3
MCO
73
3
C
58
-2
DVN
16
3
MS
74
-2
PX
75
5
MUR
43
3
AMGN
44
5
SYK
64
-4
AIG
38
-4
DAL
80
-4
MRK
22
3
M
20
-4
FDX
36
-4
XYL
37
2
DVA
72
2
SRE
63
-3
ALLE
37
5
JNPR
46
3
KR
34
-3
BEN
45
3
MCO
73
3
C
58
-2
DVN
16
3
MS
74
-2
PX
75
5
MUR
43
3
AMGN
44
5
SYK
64
-4
AIG
38
-4
DAL
80
-4
MRK
22
3
M
20
-4
Financhill
Back

ImmunityBio 10K Form

Buy
52

IBRX
ImmunityBio

Last Price:
5.04
Seasonality Move:
73.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IBRX News And Ratings

See the #1 stock for the next 7 days that we like better than IBRX

IBRX Financial Statistics

Sales & Book Value

Annual Sales: $622K
Cash Flow: $-101.56M
Price / Cash Flow: 0
Annual Sales: $-1.07
Price / Book: 0

Profitability

EPS (TTM): -0.90000
Net Income (TTM): $-587.79M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -136.92%

ImmunityBio Earnings Forecast

Key ImmunityBio Financial Ratios

  • The Research & Development expenses have been 37,357.88% of Revenue.
  • The Interest Expense is -22.15% of Operating Income.
  • The Net Earning history of IBRX is -93,761.41% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 0 years.

ImmunityBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IBRX
Website: immunitybio.com

Debt

Debt-to-Equity Ratio: -0.94
Current Ratio: 2.68
Quick Ratio: 2.22

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IBRX Technical Analysis vs Fundamental Analysis

Buy
52
ImmunityBio (IBRX) is a Buy

Is ImmunityBio a Buy or a Sell?

  • ImmunityBio stock is rated a Buy
    The current ImmunityBio [IBRX] share price is $4.88. The Score for IBRX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.